Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc.（ARCT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
arct · 股价预测 · 21 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 21 位华尔街分析师
Buy
21 位分析师
共识
评级分布
12 个月目标价
High
$25.00
Consensus
$22.50
+216.0% upside
Low
$20.00
Median: $22.5 · Last Close: $7.12
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$22.50
216.0% upside
High Target
$25
251.1%
Low Target
$20
180.9%
Current Price
$7.12
as of today
Based on analyst price targets, the ARCT stock price prediction for the next 12 months ranges from $20 to $25. The consensus ARCT price forecast of $22.50 implies 216.0% upside from the current price of $7.12.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.11 | ↓ 0.20% |
1-day model range: $7.05–$7.16. Peak: $7.16 (-0.20%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ARCT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-18 | B. Riley Securities | Upgrade ↑ | Neutral→Buy |
| 2026-03-05 | Citigroup | Maintains | Buy→Buy |
| 2026-03-04 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-04 | Citigroup | Maintains | Neutral→Neutral |
| 2026-01-06 | Citigroup | Maintains | Neutral→Neutral |
| 2025-11-13 | Citigroup | Maintains | Neutral→Neutral |
| 2025-11-11 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2025-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-10-24 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-23 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Arcturus Therapeutics Holdings Inc. (ARCT) stock. Of the recent 115 rating actions, 9 were upgrades and 21 were downgrades. 21 analysts currently cover ARCT.
分析师推荐趋势
ARCT analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$16M
↓ 65.5% YoY
Revenue Next Year
$35M
↑ 121.5% YoY
EPS This Year
$-4.06
EPS Next Year
$-3.95
↓ 2.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast ARCT EPS of $-4.06 for the current fiscal year, based on estimates from 8 analysts. The ARCT revenue forecast is $16M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ARCT 股价预测由两类独立数据源支撑：来自 21 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ARCT 的共识目标价为 $22.50（+216.0% 上行空间），分析师共识为 Buy。
ARCT 的短期预测（明日）为 $7.11（-0.20%）。
Arcturus Therapeutics Holdings Inc. 在 NASDAQ 上市，代码 ARCT。ARCT 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。
常见问题
ARCT 预测 · 8 个问题根据 21 位华尔街分析师，ARCT 的 12 个月平均目标价为 $22.50，最高 $25.00、最低 $20.00。若有图表，中位目标价可在上方查看。相对当前价 $7.12，隐含约 +216.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.